Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference93 articles.
1. Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375.
2. National Institute for Health and Care Excellence Glossary. http://www.nice.org.uk/website/glossary/glossary.jsp?alpha=P. Published April 15, 2011; July 7, 2013.
3. Mandrekar SJ, Sargent DJ. Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges. J Clin Oncol. 2009;27:4027–4034.
4. Yamauchi H, Stearns V, Hayes DF. When is a tumor marker ready for prime time? a case study of c-erbB-2 as a predictive factor in breast cancer. J Clin Oncol. 2001;19:2334–2356.
5. US Food and Drug Administration. Design Considerations for Pivotal Clinical Investigations for Medical Devices. Issued on November 7. Rockville, MD: FDA; 2013.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献